Vital Farms, Inc. (VITL) Financial Statements
Vital Farms, Inc. (VITL) reported trailing twelve-month revenue of $765.7M (up 16.4% year on year) and net income of $156000 as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: -$126.1M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
VITLVital Farms, Inc.Follow VITL — free
—
Price chart with a free account
- Market cap
- 392.4M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|
| Revenue | 214.3 | 260.9 | 362.1 | 471.9 | 606.3 | 759.4 | 765.7 | |
| Gross profit | 74.5 | 82.9 | 109.4 | 162.3 | 229.9 | 285.7 | 215.3 | |
| Operating income | 12.2 | 0.1 | 2.1 | 33.3 | 63.6 | 88.4 | 0.3 | |
| Pre-tax income | 11.7 | 0.4 | 2.8 | 32.2 | 67.5 | 91.3 | 1.7 | |
| Income tax | 2.8 | -2.0 | 1.6 | 6.6 | 14.2 | 25.0 | 1.6 | |
| Net income | 8.8 | 2.4 | 1.3 | 25.6 | 53.4 | 66.3 | 0.2 | |
| Diluted EPS ($) | 0.27 | 0.06 | 0.03 | 0.59 | 1.18 | 1.44 | -0.04 | |
| Diluted shares (mn) | 32.9 | 43.3 | 43.5 | 43.3 | 45.1 | 46.0 | — |
USD millions · SEC XBRL
Vital Farms, Inc. — questions
- What is Vital Farms, Inc.'s revenue?
- $765.7M over the twelve months to 2026-06-30, up 16.4% year on year, from its 10-Q and 10-K filings.
- What is Vital Farms, Inc.'s net income?
- $156000 over the twelve months to 2026-06-30.
- What is Vital Farms, Inc.'s free cash flow?
- -$126.1M over the twelve months to 2026-06-30.
- What are Vital Farms, Inc.'s diluted earnings per share?
- $-0.04 over the twelve months to 2026-06-30.
Every figure on this page comes from Vital Farms, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.